Prevalence of Anti-HCV in Hemodialysis Patients in Taegu and Kyeongbuk, Korea.
- Author:
Young Ho SHIN
1
;
Ho Kyu KIM
;
Sung Dae CHOI
;
Yang Sik KIM
;
Hyun Su SHIN
;
Young Jun WON
;
Ill Sae LEE
;
Mun Kyu KANG
;
Jung Ho LEE
;
Sung Bae PARK
;
Hyun Chul KIM
Author Information
1. Department of Internal Medicine, Sun-Lin Hospital, Pohang, Korea.
- Publication Type:Original Article
- Keywords:
Hepatitis C Virus;
Hemodialysis;
Prevalence and risk factor
- MeSH:
Antibodies;
Daegu*;
Dialysis;
Hepacivirus;
Hepatitis C;
Humans;
Immunoenzyme Techniques;
Kidney Failure, Chronic;
Korea*;
Prevalence*;
Renal Dialysis*;
Risk Factors
- From:Korean Journal of Medicine
1998;54(5):640-646
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
To determine the prevalence and risk factor of anti-HCV in ESRD patients under chronic maitenance hemodialysis, the prevalence of serum antibodies to hepatitis C Virus(Anti-HCV) was assessed by an enzyme immunoassay (Abbott HCV EIA) in 253 patients with long-term Hemodialysis in Daegu & Kyoungbuk. 15 patients(5.9%) were anti-HCV positive. All dialysis patients had the history of transfusion. The number of transfusion units was not significant in anti-HCV positive patients(mean 17+/-20 pints) in comparison with the number in anti-HCV negative patients (mean 16+/-17 pints). The frequency of hemodialysis was also not significant in anti-HCV positive patients(mean 477+/-618 ) compared with anti-HCV negative patients (mean 462+/-616). The mean duration of hemodialysis was significantly higher(P<0.001) in the anti-HCV positive patients (74+/-42 months) in comparison with anti-HCV negative patients (45+/-41 months). We concluded that the prevalence of anti-HCV in hemodialysis patients is 5.9% and that HCV infection is significantly related with the duration of hemodialysis rather than the number of transfusion units and the frequency of hemodialysis
